A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to develop a better tolerated and more effective pharmacologic
treatment for individuals with Asperger's Disorder and Pervasive Developmental Disorder. This
is an open-label investigation of aripiprazole in the management of the maladaptive behaviors
of autistic disorder. We hypothesize that aripiprazole will be effective for reducing
aggression and repetitive behavior.